University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease

Simple item page
dc.contributor.authorKennedy, Nicholas A
dc.contributor.authorLamb, Christopher A
dc.contributor.authorBerry, Susan H
dc.contributor.authorWalker, Alan W
dc.contributor.authorMansfield, John
dc.contributor.authorParkes, Miles
dc.contributor.authorSimpkins, Rachel
dc.contributor.authorTremelling, Mark
dc.contributor.authorNutland, Sarah
dc.contributor.authorUK IBD Genetics Consortium
dc.contributor.authorParkhill, Julian
dc.contributor.authorProbert, Chris
dc.contributor.authorHold, Georgina L
dc.contributor.authorLees, Charlie W.
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.date.accessioned2018-02-20T10:31:08Z
dc.date.available2018-02-20T10:31:08Z
dc.date.issued2018-03
dc.descriptionFunding was supported by CORE, the Digestive Diseases Foundation and the Wellcome Trust [grant number 097943 to NAK, 093885 to CAL and 098051 to Alan W Walker and Julian Parkhill . Dr. Walker receives core funding support from the Scottish Government Rural and Environmental Science and Analysis Service (RESAS). We also acknowledge the NIHR Biomedical Research Centre awards to Addenbrooke’s Hospital/University of Cambridge School of Clinical Medicine and acknowledge the NIHR Newcastle Biomedical Research Centre.en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent7040296
dc.identifier115284093
dc.identifier10757943-033f-48f1-99df-a2c518f2322f
dc.identifier85050148688
dc.identifier.citationKennedy, N A, Lamb, C A, Berry, S H, Walker, A W, Mansfield, J, Parkes, M, Simpkins, R, Tremelling, M, Nutland, S, UK IBD Genetics Consortium, Parkhill, J, Probert, C, Hold, G L & Lees, C W 2018, 'The Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Disease', Inflammatory Bowel Diseases, vol. 24, no. 3, pp. 583-592. https://doi.org/10.1093/ibd/izx061en
dc.identifier.doi10.1093/ibd/izx061
dc.identifier.iss3en
dc.identifier.issn1078-0998
dc.identifier.otherORCID: /0000-0001-5099-8495/work/42316360
dc.identifier.urihttp://hdl.handle.net/2164/10060
dc.identifier.vol24en
dc.language.isoeng
dc.relation.ispartofInflammatory Bowel Diseasesen
dc.subjectCrohn’s diseaseen
dc.subjectNOD2en
dc.subjectmicrobiotaen
dc.subjectgenotypeen
dc.subjectR Medicineen
dc.subjectWellcome Trusten
dc.subject.lccRen
dc.titleThe Impact of NOD2 Variants on Fecal Microbiota in Crohn’s Disease and Controls Without Gastrointestinal Diseaseen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
The_Impact_of_NOD2_Variants_on_Fecal_Microbiota_in_Crohn_s_Disease_and_Controls_Without_Gastrointestinal_Disease.pdf
Size:
6.71 MB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description:
Download

Collections

All research
Applied Medicine research
Medical Sciences research
Rowett Institute Of Nutrition & Health research
University Office research